These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23786792)

  • 1. Quantitative EEG and apolipoprotein E-genotype improve classification of patients with suspected Alzheimer's disease.
    Hatz F; Benz N; Hardmeier M; Zimmermann R; Rueegg S; Schindler C; Miserez AR; Gschwandtner U; Monsch AU; Fuhr P
    Clin Neurophysiol; 2013 Nov; 124(11):2146-52. PubMed ID: 23786792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: a multicentric electroencephalogram study.
    Babiloni C; Benussi L; Binetti G; Cassetta E; Dal Forno G; Del Percio C; Ferreri F; Ferri R; Frisoni G; Ghidoni R; Miniussi C; Rodriguez G; Romani GL; Squitti R; Ventriglia MC; Rossini PM
    Ann Neurol; 2006 Feb; 59(2):323-34. PubMed ID: 16358334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustainable method for Alzheimer dementia prediction in mild cognitive impairment: Electroencephalographic connectivity and graph theory combined with apolipoprotein E.
    Vecchio F; Miraglia F; Iberite F; Lacidogna G; Guglielmi V; Marra C; Pasqualetti P; Tiziano FD; Rossini PM
    Ann Neurol; 2018 Aug; 84(2):302-314. PubMed ID: 30014515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls.
    Kramer G; van der Flier WM; de Langen C; Blankenstein MA; Scheltens P; Stam CJ
    Clin Neurophysiol; 2008 Dec; 119(12):2727-32. PubMed ID: 18848805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E alleles in Cuban patients with mild cognitive impairment.
    Suárez VM; Fernández Y; López Edel C; Clarke DH; Bobes MA; Riverón AM; López-Cánovas L
    Am J Alzheimers Dis Other Demen; 2014 May; 29(3):236-41. PubMed ID: 24370622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study.
    Babiloni C; Benussi L; Binetti G; Bosco P; Busonero G; Cesaretti S; Dal Forno G; Del Percio C; Ferri R; Frisoni G; Ghidoni R; Rodriguez G; Squitti R; Rossini PM
    Neuroimage; 2006 Feb; 29(3):948-64. PubMed ID: 16213753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between DCHS2 gene and mild cognitive impairment and Alzheimer's disease in an elderly Brazilian sample.
    Vieira RN; Ávila R; de Paula JJ; Cintra MT; de Souza RP; Nicolato R; Malloy-Diniz L; de Miranda DM; de Moraes EN; de Marco LA; Romano-Silva MA; Bicalho MA
    Int J Geriatr Psychiatry; 2016 Dec; 31(12):1337-1344. PubMed ID: 26876984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
    López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
    J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment.
    Chico L; Simoncini C; Lo Gerfo A; Rocchi A; Petrozzi L; Carlesi C; Volpi L; Tognoni G; Siciliano G; Bonuccelli U
    Free Radic Res; 2013 Aug; 47(8):569-76. PubMed ID: 23668794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
    Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
    Dukart J; Sambataro F; Bertolino A
    J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease.
    Ponomareva NV; Korovaitseva GI; Rogaev EI
    Neurobiol Aging; 2008 Jun; 29(6):819-27. PubMed ID: 17293007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer's Disease.
    Musaeus CS; Engedal K; Høgh P; Jelic V; Mørup M; Naik M; Oeksengaard AR; Snaedal J; Wahlund LO; Waldemar G; Andersen BB
    J Alzheimers Dis; 2018; 64(4):1359-1371. PubMed ID: 29991135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.